EVOLUTIONARY REVERSALS OF ANTIBIOTIC RESISTANCE IN EXPERIMENTAL POPULATIONS OF PSEUDOMONAS AERUGINOSA

被引:24
|
作者
Gifford, Danna R. [1 ]
MacLean, R. Craig [1 ]
机构
[1] Univ Oxford, Dept Zool, Oxford OX1 2JD, England
基金
加拿大自然科学与工程研究理事会;
关键词
Compensatory evolution; evolvability; genetic drift; probability of fixation; rifampicin; BENEFICIAL MUTATIONS; ESCHERICHIA-COLI; BIOLOGICAL COST; COMPENSATORY EVOLUTION; EVOLVABILITY; SELECTION; PERSISTENCE; ADAPTATION; MECHANISMS; BACTERIA;
D O I
10.1111/evo.12158
中图分类号
Q14 [生态学(生物生态学)];
学科分类号
071012 ; 0713 ;
摘要
Antibiotic resistance mutations are accompanied by a fitness cost, and two mechanisms allow bacteria to adapt to this cost once antibiotic use is halted. First, it is possible for resistance to revert; second, it is possible for bacteria to adapt to the cost of resistance by compensatory mutations. Unfortunately, reversion to antibiotic sensitivity is rare, but the underlying factors that prevent reversion remain obscure. Here, we directly study the evolutionary dynamics of reversion by experimentally mimicking reversion mutationssensitivesin populations of rifampicin-resistant Pseudomonas aeruginosa. We show that, in our populations, most sensitives are lost due to genetic drift when they are rare. However, clonal interference from lineages carrying compensatory mutations causes a dramatic increase in the time to fixation of sensitives that escape genetic drift, and mutations surpassing the sensitives' fitness are capable of driving transiently common sensitive lineages to extinction. Crucially, we show that the constraints on reversion arising from clonal interference are determined by the potential for compensatory adaptation of the resistant population. Although the cost of resistance provides the incentive for reversion, our study demonstrates that both the cost of resistance and the intrinsic evolvability of resistant populations interact to determine the rate and likelihood of reversion.
引用
收藏
页码:2973 / 2981
页数:9
相关论文
共 50 条
  • [31] Pathogenicity and Antibiotic Resistance of Pseudomonas aeruginosa: A Comprehensive Review
    Ahmad, Nadeem
    Siddiqui, Areena Hoda
    Sharma, Meenakshi
    Arya, Amita
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (02) : DE6 - DE13
  • [32] Crosstalk between antibiotic resistance and virulence in Pseudomonas aeruginosa
    Gustafsson, I
    Martínez, JL
    REVIEWS IN MEDICAL MICROBIOLOGY, 2005, 16 (04) : 155 - 161
  • [33] Antibiotic resistance in clinical isolates of Pseudomonas aeruginosa in Jamaica
    Brown, PD
    Izundu, A
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 16 (02): : 125 - 130
  • [34] The many antibiotic resistance and tolerance strategies of Pseudomonas aeruginosa
    Sindeldecker, Devin
    Stoodley, Paul
    BIOFILM, 2021, 3
  • [35] Antibiotic Resistance in Pseudomonas Aeruginosa is Associated with Decreased Fitness
    Sun, Zhenzhen
    Jiao, Xiaoyang
    Peng, Qing
    Jiang, Fang
    Huang, Yuanchun
    Zhang, Juan
    Yao, Fen
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 31 (2-3) : 347 - 354
  • [36] Evolutionary landscapes of Pseudomonas aeruginosa towards ribosome-targeting antibiotic resistance depend on selection strength
    Sanz-Garcia, Fernando
    Blanca Sanchez, Maria
    Hernando-Amado, Sara
    Luis Martinez, Jose
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (06)
  • [37] ANTIBIOTIC SYNERGISM IN EXPERIMENTAL PSEUDOMONAS-AERUGINOSA INFECTIONS
    DAVIS, SD
    CHUSID, MJ
    SARFF, LD
    JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (06): : 1172 - 1173
  • [38] Evolutionary rescue in populations of Pseudomonas fluorescens across an antibiotic gradient
    Ramsayer, Johan
    Kaltz, Oliver
    Hochberg, Michael E.
    EVOLUTIONARY APPLICATIONS, 2013, 6 (04): : 608 - 616
  • [39] Impact of Antibiotic Use on Carbapenem Resistance in Pseudomonas aeruginosa: Is There a Role for Antibiotic Diversity?
    Pluess-Suard, C.
    Pannatier, A.
    Kronenberg, A.
    Muehlemann, K.
    Zanetti, G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) : 1709 - 1713
  • [40] A pharmacodynamic model for the action of the antibiotic imipenem on Pseudomonas aeruginosa populations in vitro
    Berg, PH
    Voit, EO
    White, RL
    BULLETIN OF MATHEMATICAL BIOLOGY, 1996, 58 (05) : 923 - 938